Bradley Merrill Thompson and Chris Bergstrom

Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory issues. 

Chris Bergstrom is a digital health leader, for The Boston Consulting Group (BCG). At BCG, he directs digital health initiatives across large payer, provider, med tech, and bio/pharma companies. In doing so, he leverages the best of BCG Consulting, BCG Digital Ventures, BCG Gamma Data-Science, and B.Capital to help clients formulate a strategy, build a solution, and jointly invest in greenfield ventures or new business units. 

October 27, 2017
About the Authors: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory issues.  Chris Bergstrom is a digital health leader, for The Boston Consulting Group (BCG). At BCG, he directs digital health initiatives across large payer, provider, med tech, and bio/...